关于我们
Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. We employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. In our view, these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society. Marc Schneidman, Founder & CIO, has over 20 years of dedicated investing experience across the biotechnology universe.
- 网站
-
http://www.aquilocap.com
Aquilo Capital Management的外部链接
- 所属行业
- 投资管理
- 规模
- 2-10 人
- 总部
- San Francisco，CA
- 类型
- 合营企业
地点
-
获取路线
1 Letterman Drive
US，CA，San Francisco，94129